Most of the thyroid cancers found during screening were a type called papillary — which is so common in healthy people that it’s often just found after death, and never causes any problems.
Claim Context
The majority of thyroid cancers diagnosed in South Korea during the screening boom were papillary thyroid cancer, a subtype that is often slow-growing and commonly found incidentally in autopsies of people who never had symptoms.
“the additional diagnoses from screening were all papillary thyroid cancer — a histologic finding that is so prevalent in the general population that it is better considered a normal variant than a deadly disease.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
The proportion of papillary thyroid cancers among all diagnosed cases in screened vs. unscreened populations, and their 10-year progression rates.
A systematic review of 50+ studies reporting histologic subtypes and clinical outcomes of thyroid cancers detected via screening versus clinically symptomatic presentation, across diverse populations.
The natural history of screen-detected papillary thyroid cancers — whether they grow, metastasize, or cause death over 10–20 years without treatment.
A prospective cohort of 1,000 patients with screen-detected papillary thyroid cancer <1 cm, managed with active surveillance (no surgery), followed for 15 years for tumor growth, metastasis, or cancer-related death.
The prevalence of microscopic papillary thyroid cancer in thyroid tissue from autopsies of individuals with no history of thyroid disease.
A cross-sectional analysis of 1,000 thyroid glands from autopsies of individuals aged 40–80 with no known thyroid disease, using standardized histologic review to detect papillary cancer foci.
Whether patients with aggressive thyroid cancer are less likely to have papillary subtype than those with indolent disease.
A case-control study comparing 200 patients with metastatic or fatal thyroid cancer to 400 with localized, non-fatal disease, assessing histologic subtype distribution.
Expert consensus on whether papillary thyroid cancer should be classified as a disease or a benign variant in low-risk contexts.
A Delphi consensus of 25 thyroid pathologists and oncologists evaluating histologic criteria and clinical behavior of papillary thyroid cancer to define its classification.